🚀 Welcome to the Team, Rob Jenkins! 🔬
February 24, 2025

Pharmidex is thrilled to welcome Rob Jenkins as our new Principal Scientist! 🎉

We are extremely happy and grateful to have Rob join our team, bringing his expertise and passion for bioanalysis to our mission of advancing drug discovery and development.
His skills and dedication will be invaluable as we continue to deliver high-quality scientific solutions to our partners and clients.

Join us in giving Robert a warm welcome, we're excited for the journey ahead!

#Welcome #Pharmidex #Bioanalysis #DrugDiscovery #TeamGrowth

February 4, 2026
At Pharmidex , we deliver high-quality LC-MS bioanalysis to support drug development across a wide range of analysis. Our experienced team supports preclinical, translational and clinical studies, providing accurate, reliable data under GLP and GCP to help drive confident decision-making. Learn more about our LC-MS capabilities: https://www.pharmidex.com/Discovery-Bioanalysis
February 2, 2026
Pharmidex offers high-quality Clinical Chemistry services delivering accurate, reliable data to support drug development. Our expert team and robust, quality-driven workflows enable trusted results that help accelerate decision-making and strengthen collaboration with pharma companies, CROs and academic partners. By working together, we support better science and more efficient drug development. 👉 Learn more: https://www.pharmidex.com/Clinical-chemistry
January 29, 2026
Pharmidex is delighted to share that Ash Alavijeh , Head of Operations, will be attending the UK BioIndustry Association (BIA) Annual Gala Dinner at the Roundhouse, London. Ash is looking forward to connecting with pharma and biotech colleagues to explore new collaborations, partnerships, and opportunities, all with the shared goal of advancing drug discovery and development. If you’re attending, feel free to connect with Ash this evening.
More Posts